AVIC Forstar S&T (BJ:835640) Hua Yuan Zheng Quan·2025-09-16 06:14Investment Rating - The investment rating for the company is "Accumulate" (maintained) [5] Core Views - The company achieved a year-on-year increase of 11% in net profit attributable to shareholders in the first half of 2025, driven by a recovery in defense demand and active expansion into medical and low-altitude applications [5][8] - The company is expected to see a steady growth in revenue and profit, with a projected net profit of 1.00 billion, 1.45 billion, and 1.71 billion RMB for 2025-2027, corresponding to current price-to-earnings ratios of 53.4, 37.0, and 31.3 times respectively [8] Summary by Sections Market Performance - The closing price is 28.52 RMB, with a market capitalization of 5,354 million RMB and a circulating market value of 5,150.78 million RMB [3] Financial Data - In H1 2025, the company reported revenue of 408 million RMB (up 8% year-on-year) and a net profit of 37.18 million RMB (up 11% year-on-year) [8] - The company’s revenue for Q2 2025 was 219 million RMB (up 17% year-on-year and 15% quarter-on-quarter), with a net profit of 24.81 million RMB (up 22% year-on-year and 101% quarter-on-quarter) [8] Revenue and Profit Forecast - Revenue is projected to be 886 million RMB in 2025, with a year-on-year growth rate of 16.16% [7] - The net profit for 2025 is estimated at 100 million RMB, reflecting a significant recovery from a decline in 2024 [7] Business Expansion - The company is focusing on strategic emerging industries, with a notable increase in defense orders and expansion into medical, maritime, and low-altitude economic sectors [8] - The company’s revenue from overseas markets grew by 69.42% year-on-year, indicating progress in international expansion [8] R&D and Technological Development - The company maintains a high R&D expense ratio of 9%, focusing on key technologies such as high-frequency, high-speed, and lightweight solutions [8] - The company is actively developing quantum communication technologies and has made breakthroughs in the medical and maritime sectors [8]